Clonal Evolution Of The Her2 L755s Mutation Leads To Acquired Her-Targeted Therapy Resistance That Can Be Reversed By The Irreversible Her1/2 Inhibitor AfatinibXiaowei Xu,Agostina Nardone,Huizhong Hu,Lanfang Qin,Sarmistha Nanda,Tamika Mitchell,Mj Shea,Laura M. Heiser,Nicholas Wang,Kyle Covington,Edward S. Chen,Alexander Renwick,Tao Wang,Carmine De Angelis,Alejandro Contreras,Carolina Gutierrez,Suzanne A. W. Fuqua,Gary C. Chamness,Chad A. Shaw,David A. Wheeler,Joe W. Gray,Susan G. Hilsenbeck,Mothaffar F. Rimawi,Kent Osborne,Rachel SchiffFASEB JOURNAL(2016)引用 0|浏览69暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要